Epinephrine Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Epinephrine Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Report Description
Epinephrine injection is used along with emergency medical treatment to treat life-threatening allergic reactions caused by insect bites, foods, medications, and other causes. The epinephrine auto-injectors are disposable, prefilled automatic injection devices, which are intended for self-administration of epinephrine solution in an emergency for on-the-spot treatment during early onset of symptoms of an anaphylactic reaction.
Market Dynamics
Increasing prevalence of food allergies is a major factor driving epinephrine market growth. According to a research conducted by the Centers for Disease Control and Prevention (CDC) in 2013, in the U.S., from 1997 to 2011, food allergies among children increased around by 50%. Moreover, according to the European Academy of Allergy and Clinical Immunology (EAACI), over 17 million people in Europe were affected by food allergy in 2015. For instance, in November 2021, Kaléo, Inc. received the FDA approval for its supplemental New Drug Application (sNDA) for AUVI-Q, the first and only epinephrine auto-injector (EAI) specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and small children weighing 16.5 to 33 pounds.
Key features of the study:
This report provides in-depth analysis of the epinephrine market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global epinephrine market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Mylan N.V., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Impax Laboratories, Inc., Kaleo, Inc., Adamis Pharmaceuticals Corporation, Bausch Health Companies, ALK- Abello A/S
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global epinephrine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the epinephrine market

Detailed Segmentation:
Global Epinephrine Market, By Product Type:
Auto-injector
Prefilled Syringes
Ampoules and Vials
Global Epinephrine Market, By Application:
Anaphylaxis
Cardiac Arrest
Superficial Bleeding
Respiratory Disorders
Others
Global Epinephrine Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Epinephrine Market, By Geography:
North America
By Product Type:
Auto-injector
Prefilled Syringes
Ampoules and Vials
By Application:
Anaphylaxis
Cardiac Arrest
Superficial Bleeding
Respiratory Disorders
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Product Type:
Auto-injector
Prefilled Syringes
Ampoules and Vials
By Application:
Anaphylaxis
Cardiac Arrest
Superficial Bleeding
Respiratory Disorders
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Auto-injector
Prefilled Syringes
Ampoules and Vials
By Application:
Anaphylaxis
Cardiac Arrest
Superficial Bleeding
Respiratory Disorders
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Auto-injector
Prefilled Syringes
Ampoules and Vials
By Application:
Anaphylaxis
Cardiac Arrest
Superficial Bleeding
Respiratory Disorders
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Auto-injector
Prefilled Syringes
Ampoules and Vials
By Application:
Anaphylaxis
Cardiac Arrest
Superficial Bleeding
Respiratory Disorders
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Auto-injector
Prefilled Syringes
Ampoules and Vials
By Application:
Anaphylaxis
Cardiac Arrest
Superficial Bleeding
Respiratory Disorders
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Mylan N.V.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Impax Laboratories, Inc.
Kaleo, Inc.
Adamis Pharmaceuticals Corporation
Bausch Health Companies
ALK- Abello A/S
“*” marked represents similar segmentation in other categories in the respective section.